M4MM
IRS Pushes Back on Cannabis Tax Refund Claims as the 280E Battle Enters a New Era
WASHINGTON, D.C.-The Cannabis industry's long-running battle with Section 280E has entered a pivotal new phase. For years, one of the greatest financial challenges facing state-licensed Cannabis businesses has not been competition or regulation—it has been ...
Organigram Highlights Early Sanity Results While Holding Canadian Market Lead
TORONTO – Three months after closing its largest international acquisition to date, Organigram Global Inc. has delivered the first combined business update covering Sanity Group's early performance alongside the company's ongoing Canadian market position. The ...
Colder BHO Extractions Yield Cleaner Cannabis Concentrates, Abstrax Study Finds
LOS ANGELES – Researchers at Abstrax Tech have found that colder extraction temperatures during butane hash oil (BHO) processing significantly reduce the carryover of plant-derived wax compounds into finished concentrates, without meaningfully affecting cannabinoid potency ...
Nebraska Takes First Step Toward State-Grown Medical Cannabis Supply
LINCOLN – Nebraska’s medical Cannabis program, approved by voters in 2024, has reached a notable early milestone. State regulators recently authorized the first licensed cultivator to begin planting, marking concrete progress in building a regulated ...
Ora Pharm Completes Helius Acquisition, Becomes New Zealand’s Largest Medical Cannabis Company
AUCKLAND – Ora Pharm has completed the acquisition of the key assets of Helius Therapeutics and restarted manufacturing operations. The agreement covers Helius's EU-GMP-certified production plant, its remaining inventory, and its operating licenses, though it ...
Glass House Brands Triggers Warrant Acceleration
LONG BEACH – Glass House Brands Inc., a major player in California Cannabis production and retail, has told holders of warrants issued in two earlier financing rounds that their right to convert those securities into ...
Week in Review: Cannabis & Psychedelics Industry Highlights
LOS ANGELES – Two weeks of headlines confirm a market sorting itself by balance sheet rather than by ambition. Cannabis is consolidating into a smaller circle of disciplined operators, while psychedelics graduate from pilot programs ...
IRS Pushes Back on Cannabis Tax Refund Claims as the 280E Battle Enters a New Era
WASHINGTON, D.C.-The Cannabis industry's long-running battle with Section 280E has entered a pivotal new phase. For years, one of the greatest financial challenges facing state-licensed Cannabis businesses has not been competition or regulation—it has been ...
Organigram Highlights Early Sanity Results While Holding Canadian Market Lead
TORONTO – Three months after closing its largest international acquisition to date, Organigram Global Inc. has delivered the first combined business update covering Sanity Group's early performance alongside the company's ongoing Canadian market position. The ...
Colder BHO Extractions Yield Cleaner Cannabis Concentrates, Abstrax Study Finds
LOS ANGELES – Researchers at Abstrax Tech have found that colder extraction temperatures during butane hash oil (BHO) processing significantly reduce the carryover of plant-derived wax compounds into finished concentrates, without meaningfully affecting cannabinoid potency ...
Cannabis Market’s Hidden Scale: New Estimates Point to $90B U.S. Potential
LOS ANGELES – Viridian Capital Advisors' latest Chart of the Week dives into recreational Cannabis sales across nine mature markets (Michigan, Montana, Alaska, New Mexico, Massachusetts, Colorado, Oregon, Washington, and Nevada) to gauge true consumer ...
Republican State AGs Challenge Trump’s Cannabis Rescheduling Directive
LOS ANGELES – A coalition of Republican attorneys general from eight states has publicly rejected President Donald Trump's recent Executive Order to reschedule Cannabis under the Controlled Substances Act, citing persistent risks to public safety ...
Banks Still Hesitant on Expanding Services for Cannabis Businesses Post-Trump Rescheduling Order
LOS ANGELES – President Donald Trump's Executive Order fast-tracked the move to reschedule Cannabis under the Controlled Substances Act, aiming to ease research barriers and tax deductions for state-legal operators. Yet even as this policy ...
Atai Gains Nasdaq Biotechnology Index Spot
NEW YORK – AtaiBeckley N.V., the clinical-stage biopharmaceutical firm born from the November merger of atai Life Sciences and Beckley Psytech, has secured a place in the Nasdaq Biotechnology Index (NBI), a move that underscores ...
Vireo Growth Acquires Eaze, Expands into California and Florida
MINNEAPOLIS – Vireo Growth Inc. announced a definitive agreement to acquire Eaze Inc. in a stock-based transaction valued at $47 million upfront, marking the company's first push into the competitive California and Florida markets. The ...
Massachusetts Cannabis Rollback Gains Legislative Traction
BOSTON – State election officials have validated more than 78,000 signatures for a measure that would dismantle the commercial side of Massachusetts' recreational Cannabis industry, thrusting the issue back into legislative hands just as the ...
U.S. Cannabis Operators Trail Canadian Counterparts in Valuation Metrics, Tied to Tax Constraints
LOS ANGELES – In the ongoing tug-of-war between regulatory challenges and market potential in the Cannabis sector, a fresh analysis underscores how a longstanding IRS provision continues to weigh on American companies. According to Viridian ...
Trump’s Rescheduling Order Ignites State Cannabis Momentum in Pennsylvania, Tennessee, and Wyoming
LOS ANGELES – President Donald Trump's directive last week to fast-track Cannabis's rescheduling has handed lawmakers in several conservative-leaning states a timely political opening to advance Cannabis reforms. The executive order, signed on December 18, ...
Week in Review: Cannabis & Psychedelics Industry Highlights
LOS ANGELES – Operators and investors wrapped up 2025 on a high note, with federal policy breakthroughs and corporate maneuvers signaling sustained growth potential across Cannabis & Psychedelics. Over the past two weeks, President Trump's ...
Texas Awards $50M Grant to Spearhead Ibogaine Trials
AUSTIN – The Texas Health and Human Services Commission has granted $50 million to a statewide consortium led by UTHealth Houston and the University of Texas Medical Branch at Galveston, marking the formal launch of ...
Vireo Growth Acquires PharmaCann Colorado Assets
DENVER – Vireo Growth Inc. reached an agreement with PharmaCann Inc. to buy its 17 operational dispensaries and related assets in Colorado for roughly $49 million in company shares, a move that bolsters Vireo's retail ...
Michigan Senate Tightens Controls on Intoxicating Hemp Derivatives
LANSING – In a bipartisan push to close regulatory gaps, the Michigan Senate approved a package of bills that would classify most high-potency hemp-derived THC items as Cannabis, folding them into the state's established Cannabis ...
Trulieve Secures $140M in Senior Notes
TALLAHASSEE – Trulieve Cannabis Corp. wrapped up a $140 million private placement of 10.5% senior secured notes, tapping into robust investor appetite to fuel its operational push. The deal, upsized from initial plans, comes just ...
🚨🚨 BREAKING: TRUMP RESCHEDULES CANNABIS 🚨🚨
WASHINGTON, D.C. –After months of speculation, President Trump Issues Executive Order Directing Federal Rescheduling of Cannabis to Schedule III President Donald Trump has signed an executive order directing federal agencies to complete the rescheduling of ...
Czech Republic Approves Psilocybin Therapy Guidelines for 2026
PRAGUE – The Czech Republic has taken a measured step toward integrating psychedelic-assisted therapy into its healthcare system, approving detailed rules that will permit the controlled use of psilocybin for select patients beginning in January ...
